Executive Profile*

Klaus R. Veitinger M.D., Ph.D.

Venture Partner,OrbiMed Advisors, L.L.C.
AgeTotal Calculated CompensationThis person is connected to 10 board members in 2 different organizations across 9 different industries.

See Board Relationships
54--

Background*

Dr. Klaus R. Veitinger, M.D., Ph.D., M.B.A., serves as the Chief Executive Officer of Symbiomix Therapeutics. Mr. Veitinger has been a Venture Partner at OrbiMed Advisors, L.L.C. Since 1990, Dr. Veitinger has held several management posts at Schwarz Pharma in the areas of drug development and strategic planning, as well as mergers and acquisitions. He served as the Chief Executive Officer and President of Schwarz Pharma, Inc. where he led the successful turnaround efforts ...

Read Full Background

Corporate Headquarters*

601 Lexington Avenue at 53rd Street
New York, New York 10022-4629

United States

Phone: 212-739-6400
Fax: 212-739-6444

Board Members Memberships*

Chairman
Chairman

Education*

Doctorate
INSEAD
MBA
INSEAD
PhD 1988
University of Heidelberg
Bachelor's Degree
University of Heidelberg
MD 1988
University of Heidelberg

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.